KRYS - Krystal Biotech, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development7,7613,208741
Selling General and Administrative4,1551,564402
Non Recurring---
Total Operating Expenses11,9164,7721,143
Operating Income or Loss-11,916-4,772-1,143
Income from Continuing Operations
Total Other Income/Expenses Net1,027-3,148-7
Earnings Before Interest and Taxes-11,916-4,772-1,143
Interest Expense--3,200-7
Income Before Tax-10,889-7,920-1,150
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-10,889-7,920-1,150
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-10,889-7,920-1,150
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,889-7,920-1,150